Else Nutrition Stock Price, News & Analysis (CVE:BABY)

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Else Nutrition in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BABY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BABY, but not buy additional shares or sell existing shares.
View BABY analyst ratings or view top-rated stocks.

1 brokerages have issued 1-year target prices for Else Nutrition's stock. Their BABY share price targets range from C$0.45 to C$0.45. On average, they anticipate the company's stock price to reach C$0.45 in the next twelve months. This suggests that the stock has a possible downside of 61.5%.
View analysts price targets for BABY or view top-rated stocks among Wall Street analysts.

Else Nutrition's stock was trading at C$1.17 at the start of the year. Since then, BABY shares have increased by 0.0% and is now trading at C$1.17.
View the best growth stocks for 2023 here.

Based on aggregate information from My MarketBeat watchlists, some companies that other Else Nutrition investors own include iQIYI (IQ), Bank of Queensland (BOQ), Nokia Oyj (NOK), CV Sciences (CVSI), iSIGN Media Solutions (ISD), Nikola (NKLA), Royal Dutch Shell (RDSB), AeroVironment (AVAV) and

Shares of BABY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.